DG 5128

Known as: DG-5128 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1981-1997
0246819811997

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1991
1991
The selective alpha 2-antagonist DG-5128 provoked a dose-dependent stimulation of insulin release from isolated rat islets. DG… (More)
Is this relevant?
1988
1988
To study the possible role of alpha-2 receptors in intractable asthmatics, we investigated the ameliorative effects of 2-[2-(4,5… (More)
Is this relevant?
1987
1987
Midaglizole (DG-5128), 2-[2-(4,5-dihydro-1H-imidazol-2-yl)-1-phenylethyl]pyridine dihydrochloride sesquihydrate, is a novel alpha… (More)
Is this relevant?
1987
1987
Midaglizole (DG-5128), 2-[2-(4,5-dihydro-1H-imidazol-2-yl)-1-phenylethyl]pyridine dihydrochloride sesquihydrate, is a new type of… (More)
Is this relevant?
1987
1987
2[2-(4.5-Dihydro-1H-imidazol-2-yl)-1-phenylethyl] pyridine dihydrochloride sesquihydrate (DG-5128) is an alpha 2-specific… (More)
Is this relevant?
1986
1986
Effects of oral administration of DG-5128, a new oral hypoglycemic agent, on glycemic control after a mixed meal and an in vivo… (More)
Is this relevant?
1984
1984
DG-5128 (2-[2-(4,5-dihydro-1H-imidazol-2-yl)-1-phenylethyl]pyridine dihydrochloride sesquihydrate) at concentrations up to 10… (More)
Is this relevant?
1983
1983
The effects of a new hypoglycemic agent, DG-5128 (2-[2-(4,5-dihydro-1H-imidazol-2-yl)-1-phenylethyl]pyridine dihydrochloride… (More)
Is this relevant?
1982
1982
2-[2-(4,5-dihydro-1H-imidazol-2-yl)-1-phenylethyl] pyridine dihydrochloride sesquilhydrate (DG-5128) is a new orally effective… (More)
Is this relevant?
1982
1982
2-[2-(4,5-Dihydro-1H-imidazol-2-yl)-1-phenylethyl]pyridine dihydrochloride sesquihydrate (GD-5128) is a new hypoglycemic agent… (More)
Is this relevant?